Qingxin Yang

Shenzhen University

Papers

3

Total Citations

159

H-Index

3

About

Qingxin Yang is a pioneering researcher at the intersection of microrobotics, nanomedicine, and targeted cancer therapy. Their work focuses on engineering biohybrid microrobots—combining living cells, natural materials, and magnetic propulsion—to overcome biological barriers in drug delivery. Yang’s most impactful contribution is the development of magnetic-powered Janus cell robots loaded with oncolytic adenovirus for active virotherapy of bladder cancer (101 citations), a breakthrough that uses modified 293T cells as “Trojan horses” for tumor-selective killing. They further advanced the field by creating sperm-based microrobots protected by metal-organic framework exoskeletons (38 citations), solving the challenge of immune attack on living microswimmers. In a creative fusion of traditional medicine and robotics, Yang also engineered pollen typhae-based magnetic microrobots for acute gastric bleeding treatment (20 citations), demonstrating how ancient herbal remedies can be repurposed as active therapeutic platforms. Their work has been published in top journals including *Advanced Materials* and *ACS Nano*, and they are recognized for redefining the boundaries of active drug delivery—showing that the future of precision medicine may be microscopic, mobile, and alive.

Research Focus

Key Achievements

3
H-Index
3
Papers
159
Total Citations
53
Avg Citations/Paper
🏆 Most Cited Paper
Magnetic‐Powered Janus Cell Robots Loaded with Oncolytic Adenovirus for Active and Targeted Virotherapy of Bladder Cancer
101 citations · 2022
📈 Most Prolific Year: 2022 (2 Papers)
🤝 Key Collaborators: 16
🏛 Institutions: Shenzhen University

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago